Brazilian Grower Places First Commercial Order for Agrarius Across 384,000 Citrus Trees
MLCO is trading near its 52-week low of $3.67 (14% above the low).
Summary
A Brazilian citrus grower that hosted the Agrarius trials placed an initial order for a planned commercial program covering roughly 384,000 trees — the first real commercial commitment for the licensed plant-signaling product. The order follows FARMATAC's second-cycle pre-harvest assessment, which estimated Hamlin yield of 1,657.9 boxes per hectare versus 981.3 under standard management, about a 69% increase, plus a 62.7% lift in estimated concentrated-juice output per hectare. The grower's 2026 main-harvest records separately showed 1,041 versus 710 boxes per hectare, a 46.6% gain. This builds on the first-cycle citrus results announced December 1, 2025, and moves Agrarius from evaluation toward commercial adoption in Latin America. The caveats are real: this is a single orchard, the order is initial and not guaranteed to complete, and the company explicitly does not claim Agrarius treats or cures citrus greening. For a micro-cap trading near three cents, a named grower converting to a commercial program is the kind of validation that can re-rate the story — but revenue is still unquantified and the press release discloses no dollar terms.
At the time of this announcement, MLCO was trading at $4.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $3.67 to $9.53. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.